Influenza (Seasonal Flu)

Annual burden of influenza globally and in the U.S., how seasonal flu vaccines are formulated each year, measured effectiveness data by season, and high-risk population guidance.

Disease Overview

Influenza Burden Worldwide

Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It causes mild to severe illness and can lead to death.

1 Billion
Annual Cases Globally
WHO estimates
3-5 Million
Severe Cases Annually
WHO estimates
290,000-650,000
Annual Deaths
WHO estimates
9-41 Million
U.S. Cases Annually
CDC estimates

Who Is Most at Risk?

  • Adults 65 years and older
  • Young children (under 5, especially under 2)
  • Pregnant women
  • People with chronic medical conditions
  • People with weakened immune systems
  • Healthcare workers
  • American Indian/Alaska Native populations
  • Obesity (BMI 40+)
Historical Context

Pre-Vaccine Era

Before the availability of influenza vaccines, seasonal flu epidemics caused significant mortality, particularly during pandemics.

1918
Spanish Flu Pandemic
Estimated 50 million deaths worldwide (3-5% of global population). The H1N1 virus spread rapidly due to World War I troop movements.
1957
Asian Flu Pandemic
Estimated 1-2 million deaths globally. First identified in Guizhou, China.
1968
Hong Kong Flu Pandemic
Estimated 1 million deaths globally. Caused by H3N2 virus.

Annual U.S. Impact (Pre-Vaccine Widespread Use)

Hospitalizations 140,000-810,000
Deaths 12,000-52,000
Peak Season December-February

CDC. "Flu Symptoms & Complications."

Vaccine Information

Influenza Vaccines

Several types of influenza vaccines are available, updated annually to match circulating strains.

Quadrivalent Inactivated Vaccine (IIV4)

Protects against 4 influenza strains (2 A, 2 B). Standard dose for adults 18-64.

Fluzone Fluvirin Afluria

Quadrivalent Live Attenuated (LAIV4)

Nasal spray vaccine for non-pregnant individuals ages 2-49.

FluMist

High-Dose & Adjuvanted

For adults 65+. Enhanced immune response in older adults.

Fluzone High-Dose Fluad

Vaccine Effectiveness by Season

Season Overall Effectiveness Match to Circulating Strains
2023-2024 36-52% Good match
2022-2023 28-37% Moderate match
2021-2022 31-35% Good match
2020-2021 38-49% Very good match
2019-2020 39% (lower for B) Mixed match

Source: CDC. "Seasonal Flu Vaccine Effectiveness Studies."

Sources & Citations

Primary Sources

Related Pages

Explore more vaccine-preventable diseases and resources